MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
4.195
+0.135
+3.33%
Opening 12:14 11/22 EST
OPEN
4.080
PREV CLOSE
4.060
HIGH
4.199
LOW
4.040
VOLUME
121.29K
TURNOVER
--
52 WEEK HIGH
14.75
52 WEEK LOW
3.850
MARKET CAP
109.49M
P/E (TTM)
-0.9348
1D
5D
1M
3M
1Y
5Y
1D
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals
Benzinga · 3d ago
Inovio Pharma Price Target Cut to $5.00/Share From $12.00 by HC Wainwright & Co.
Dow Jones · 4d ago
Inovio Pharma Is Maintained at Neutral by HC Wainwright & Co.
Dow Jones · 4d ago
HC Wainwright & Co. Maintains Neutral on Inovio Pharmaceuticals, Lowers Price Target to $5
Benzinga · 4d ago
Inovio Pharma Is Maintained at Outperform by Oppenheimer
Dow Jones · 4d ago
Inovio Pharma Price Target Cut to $15.00/Share From $33.00 by Oppenheimer
Dow Jones · 4d ago
Oppenheimer Maintains Outperform on Inovio Pharmaceuticals, Lowers Price Target to $15
Benzinga · 4d ago
Inovio price target lowered to $15 from $33 at Oppenheimer
TipRanks · 4d ago
More
About INO
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.

Webull offers Inovio Pharmaceuticals Inc stock information, including NASDAQ: INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.